Aktis Oncology Inc logo

Aktis Oncology Inc

AKTS
Healthcare|Biotechnology|USA
$27.88
-0.54 (-1.90%)
Tangible Book
$9.16

Upcoming Data Readouts (2)

Dec 2027
Est. completion
P1Urothelial Carcinoma Bladder
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
NCT07020117n=150
Dec 2027
Est. completion
P1Castration Resistant Metastatic Prostate Cancer
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07581184n=138

Recent Press Releases